PATENT CLAIM ANALYSIS

Application Number: 15752845
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "325000"]

Abstract:
The present invention relates to compositions and methods for disrupting cancer stromal cell networks using synthetic nanoparticles coated with plasma membranes.

Claim (Index 23):
The composition of  claim 22 , wherein the cancer is selected from the group consisting of breast cancer, skin cancer, lung cancer, brain cancer, pancreatic cancer, esophageal cancer, stomach cancer, liver cancer, kidney cancer, colorectal cancer, intestinal cancer, bladder cancer, prostate cancer, ovarian cancer, uterine cancer, testicular cancer, sarcoma, lymphoma, leukemia, retinoblastoma, oral cancer, bone cancer, neoplasia, dysplasia, and glioma.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15545937', '14449590', '15699796', '14233215', '14726770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.664391740255006
- 35 USC 102 Novelty (BERT): 0.508143100099094
- Combined Prediction Score: 0.6487668762394149
- Mean Citation Score: 245.999092
- Max Citation Score: 259.45413
- Similarity Product: 157.80670160696985

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test